A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
Conditions
Cutaneous Squamous Cell Carcinoma · SCC - Squamous Cell Carcinoma · Basal Cell Carcinoma · BCC · BCC - Basal Cell Carcinoma · Melanoma · Merkel Cell Carcinoma · Sebaceous Carcinoma · Extramammary Paget Disease · Kaposi Sarcoma · Head and Neck Squamous Cell Carcinoma · HNSCC · Adnexal Carcinoma · Angiosarcoma · Cutaneous Neoplasm · Advanced Cancer · Metastatic Cancer · Refractory Cancer · Solid Tumor
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown, New Jersey, United States
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States
Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities), Commack, New York, United States
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, United States
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States
Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale, New York, United States
Study leads
Lara Dunn, MD
Principal Investigator
Memorial Sloan Kettering Cancer Center